首页> 外国专利> RECOMBINANT ANTIBODY, PHARMACEUTICAL PREPARATION, DIAGNOSTIC PREPARATION, METHOD FOR IDENTIFYING CANDIDATE ANTIBODY, METHOD OF TREATING, PREVENTING AND DIAGNOSING SUBJECTS SUSCEPTIBLE TO RISK OF INFECTION OR SUFFERING INFECTIONS CAUSED BY MULTIDRUG-RESISTANT STRAINS OF E.COLI

RECOMBINANT ANTIBODY, PHARMACEUTICAL PREPARATION, DIAGNOSTIC PREPARATION, METHOD FOR IDENTIFYING CANDIDATE ANTIBODY, METHOD OF TREATING, PREVENTING AND DIAGNOSING SUBJECTS SUSCEPTIBLE TO RISK OF INFECTION OR SUFFERING INFECTIONS CAUSED BY MULTIDRUG-RESISTANT STRAINS OF E.COLI

机译:重组抗体,药物制剂,诊断制剂,鉴定候选抗体的方法,治疗,预防和诊断可能由多药耐药株引起的感染或感染风险的对象。

摘要

FIELD: biochemistry.;SUBSTANCE: invention relates to biochemistry, in particular to an antibody for treating or preventing an infectious disease caused by the O25b antigen. Also disclosed are a pharmaceutical preparation and a diagnostic preparation containing said antibody. Disclosed is a candidate antibody identification method, use of said antibody for prevention and diagnosis.;EFFECT: invention has the ability effectively treat diseases caused by O25b antigen.;10 cl, 4 ex, 1 tbl, 7 dwg
机译:技术领域本发明涉及生物化学,尤其涉及用于治疗或预防由O25b抗原引起的感染性疾病的抗体。还公开了包含所述抗体的药物制剂和诊断制剂。公开了一种候选抗体鉴定方法,该抗体用于预防和诊断。效果:本发明具有有效治疗由O25b抗原引起的疾病的能力。10 cl,4 ex,1 tbl,7 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号